Parallel Advisors’s Nu Skin NUS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$62.2K Buy
11,777
+8,278
+237% +$52.9K ﹤0.01% 1996
2026
Q1
$25.5K Buy
3,499
+1,030
+42% +$9.33K ﹤0.01% 2365
2025
Q4
$23.8K Buy
2,469
+2,104
+576% +$21.8K ﹤0.01% 2200
2025
Q3
$4.45K Sell
365
-14
-4% -$147 ﹤0.01% 2831
2025
Q2
$3.03K Sell
379
-593
-61% -$4.16K ﹤0.01% 2919
2025
Q1
$7.06K Sell
972
-533
-35% -$3.88K ﹤0.01% 2567
2024
Q4
$10.4K Buy
1,505
+1,432
+1,962% +$9.85K ﹤0.01% 2403
2024
Q3
$538 Sell
73
-3,174
-98% -$29.7K ﹤0.01% 3170
2024
Q2
$34.2K Buy
3,247
+3,096
+2,050% +$39.2K ﹤0.01% 1715
2024
Q1
$2.09K Sell
151
-372
-71% -$5.81K ﹤0.01% 2815
2023
Q4
$10.2K Sell
523
-183
-26% -$3.38K ﹤0.01% 2286
2023
Q3
$15K Buy
706
+421
+148% +$10.9K ﹤0.01% 2001
2023
Q2
$9.46K Sell
285
-360
-56% -$13.3K ﹤0.01% 2190
2023
Q1
$25.4K Sell
645
-14
-2% -$582 ﹤0.01% 1716
2022
Q4
$27.8K Sell
659
-3
-0.5% -$115 ﹤0.01% 1564
2022
Q3
$22K Sell
662
-29
-4% -$1.21K ﹤0.01% 1645
2022
Q2
$30K Sell
691
-49
-7% -$2.25K ﹤0.01% 1480
2022
Q1
$35K Buy
740
+53
+8% +$2.63K ﹤0.01% 1456
2021
Q4
$35K Buy
687
+396
+136% +$17.6K ﹤0.01% 1528
2021
Q3
$12K Sell
291
-3
-1% -$152 ﹤0.01% 1993
2021
Q2
$17K Sell
294
-31
-10% -$1.76K ﹤0.01% 1765
2021
Q1
$17K Sell
325
-60
-16% -$3.27K ﹤0.01% 1675
2020
Q4
$21K Sell
385
-135
-26% -$7.1K ﹤0.01% 1456
2020
Q3
$26K Sell
520
-12,725
-96% -$603K ﹤0.01% 1335
2020
Q2
$506K Buy
13,245
+13,180
+20,277% +$424K 0.03% 292
2020
Q1
$1K Buy
+65
New +$1.96K ﹤0.01% 2299
2018
Q1
Sell
-91
Closed -$6K 2146
2017
Q4
$6K Hold
91
﹤0.01% 1495
2017
Q3
$6K Hold
91
﹤0.01% 1502
2017
Q2
$6K Buy
+91
New +$5.19K ﹤0.01% 1522

Other funds holding NUS

Parallel Advisors's NUS Position: Q2 2026 in Review

Parallel Advisors increased its Nu Skin (NUS) stake by 237% in Q2 2026, buying an estimated $52.9K and bringing the position to 11,777 shares worth $62.2K. The position accounts for ﹤0.01% of the portfolio, ranked #1996.

Parallel Advisors first reported a position in NUS in Q2 2017 and has held it in 29 quarters since. The position peaked at $506K in Q2 2020. 161 funds tracked by Wall St. Rank hold NUS as of Q2 2026.

  • Parallel Advisors held 11,777 shares of Nu Skin worth $62.2K as of Q2 2026.
  • Parallel Advisors bought 8,278 Nu Skin shares in Q2 2026, an estimated $52.9K.
  • Nu Skin made up ﹤0.01% of Parallel Advisors's portfolio in Q2 2026, its #1996 holding.
  • Parallel Advisors first reported a position in Nu Skin in Q2 2017 and has held it in 29 quarters since.
  • Parallel Advisors's Nu Skin position peaked at $506K in Q2 2020.
  • 161 funds tracked by Wall St. Rank held Nu Skin as of Q2 2026.

Based on Parallel Advisors's 13F filing for Q2 2026, filed 5 Aug 2026.